Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Cash from Operations (2022 - 2025)

CervoMed (CRVO) has disclosed Cash from Operations for 9 consecutive years, with 6575699.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 18.32% to 6575699.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 23449963.0 through Dec 2025, down 41.86% year-over-year, with the annual reading at 23449963.0 for FY2025, 41.86% down from the prior year.
  • Cash from Operations hit 6575699.0 in Q4 2025 for CervoMed, down from 6465210.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 6856778.0 in Q3 2022 to a low of 8050918.0 in Q4 2024.
  • Historically, Cash from Operations has averaged 3125212.25 across 4 years, with a median of 3216406.5 in 2023.
  • Biggest YoY gain for Cash from Operations was 68.67% in 2023; the steepest drop was 266.55% in 2023.
  • Year by year, Cash from Operations stood at 692530.0 in 2022, then crashed by 266.55% to 2538454.0 in 2023, then crashed by 217.16% to 8050918.0 in 2024, then grew by 18.32% to 6575699.0 in 2025.
  • Business Quant data shows Cash from Operations for CRVO at 6575699.0 in Q4 2025, 6465210.0 in Q3 2025, and 6514695.0 in Q2 2025.